Archives
-
CB-5083: Applied Protocols for Selective p97 Inhibitor Workf
2026-05-25
CB-5083 empowers precise disruption of protein homeostasis and apoptosis induction in cancer and cell biology research. This guide distills advanced workflows, troubleshooting, and novel insights for maximizing p97 inhibition in both in vitro and in vivo settings, building on the latest mechanistic and translational findings.
-
Disrupting SARS-CoV-2 Nucleocapsid LLPS: GCG’s Novel Antivir
2026-05-25
The referenced study reveals that the SARS-CoV-2 nucleocapsid protein relies on RNA-triggered liquid–liquid phase separation (LLPS) for viral replication. Targeting this process, (-)-gallocatechin gallate (GCG) effectively inhibits both LLPS and viral propagation, opening a new avenue for antiviral research and chemical probe development.
-
Mitochondrial NAD+ Deficiency Drives Aortic Aneurysm via Col
2026-05-24
This study uncovers mitochondrial NAD+ deficiency in vascular smooth muscle as a previously unrecognized cause of thoracic and abdominal aortic aneurysm. Through multiomics and genetic models, the authors link impaired mitochondrial NAD+ homeostasis to defective collagen III turnover, offering new mechanistic insight and highlighting potential molecular targets in aortic disease.
-
PA-Src-FAK-RhoA/ROCK Pathway Drives Decidual Cytoskeletal Ch
2026-05-23
This study illuminates the critical role of the phosphatidic acid (PA)-Src-FAK-RhoA/ROCK pathway in orchestrating cytoskeletal rearrangements during decidualization of human endometrial stromal cells. These findings refine our understanding of endometrial remodeling and suggest new molecular targets for investigating implantation-related infertility.
-
Cytoskeleton-Dependent Mechanotransduction in Autophagy Indu
2026-05-22
This study establishes that mechanical stress-induced autophagy in human cells is critically dependent on the cytoskeleton, particularly on microfilaments. By pharmacologically modulating cytoskeletal components, the authors provide mechanistic clarity on how cells convert mechanical cues into autophagic responses, offering a foundation for future research into mechanotransduction and calcium signaling pathways.
-
CD44-Driven Metabolic Rewiring in IDH-Mutant AML: Therapeuti
2026-05-22
The reference study identifies CD44-mediated metabolic rewiring as a critical dependency in IDH-mutant acute myeloid leukemia (AML), enabling sustained NADPH generation for elevated (R)-2-hydroxyglutarate production. Targeting this axis, especially in combination with IDH2 inhibition, unveils new avenues for overcoming resistance in hematologic malignancies with IDH mutations.
-
Methyl-β-cyclodextrin: Technical Guidance for Membrane Studi
2026-05-21
Methyl-β-cyclodextrin is used to extract cholesterol and modulate lipid rafts in cell membrane research, enabling precise studies of membrane fluidity and cholesterol-dependent signaling. It is not intended for diagnostic or therapeutic use, and its efficacy depends on proper solubilization, storage, and protocol adherence.
-
SNAI1–PIK3R2/p-EphA2 Axis Drives EMT and Stemness in TETs
2026-05-21
This study identifies SNAI1 as a central regulator of epithelial-mesenchymal transition (EMT) and cancer stem cell-like properties in thymic epithelial tumors (TETs), acting through the PIK3R2/p-EphA2 axis. These findings offer mechanistic insight into TET progression and highlight new avenues for targeted therapeutic research.
-
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1
2026-05-20
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent optimized for in vitro peptide synthesis, bioconjugation, nucleotide, and esterification reactions requiring rapid amide bond formation. It is not suitable for in vivo or clinical workflows due to the absence of supporting data.
-
SLC25A1 Upregulation Drives Cisplatin Resistance via Senesce
2026-05-20
Li et al. identify SLC25A1 as a key mediator of cisplatin resistance in head and neck squamous cell carcinoma (HNSCC) by promoting cellular senescence through H3K27ac-dependent gene activation. Their findings highlight SLC25A1 as a predictive biomarker and potential therapeutic target for overcoming chemoresistance in HNSCC.
-
METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC
2026-05-19
Wang et al. (2024) uncover how the METTL16-SENP3-LTF signaling axis confers resistance to ferroptosis and promotes tumorigenesis in hepatocellular carcinoma (HCC). This mechanistic insight highlights new potential targets for sensitizing HCC to ferroptosis-based therapies, with important implications for translational research on overcoming drug resistance.
-
MDM1 Overexpression Enhances p53-Mediated Apoptosis in CRC T
2026-05-19
This study demonstrates that MDM1 overexpression promotes p53 expression and cancer cell apoptosis, improving chemoradiotherapy sensitivity in colorectal cancer. The findings position MDM1 as both a mechanistic regulator of the p53 pathway and a predictive biomarker for therapy response.
-
KR-12 Human Antimicrobial Peptide: Dual Anti-Inflammatory an
2026-05-18
This study demonstrates that the KR-12 human antimicrobial peptide, the shortest active fragment of LL-37, significantly alleviates both inflammation and bacterial burden in multiple mouse models of colitis. The findings support KR-12 as a promising candidate for the development of targeted therapies for inflammatory bowel diseases, with strong translational relevance for anti-inflammatory and anti-infective research.
-
ISR Inhibition Prevents Inflammation-Induced Memory Forgetti
2026-05-18
This study elucidates how systemic inflammation accelerates recognition memory loss in mice via integrated stress response (ISR) activation. Pharmacological inhibition of the ISR with ISRIB (trans-isomer) reverses this accelerated forgetting, indicating therapeutic potential for cognitive impairment associated with neuroinflammation.
-
ISR Inhibition Prevents Memory Loss and Accelerated Forgetti
2026-05-17
This study demonstrates that the integrated stress response (ISR) actively regulates both natural and epilepsy-associated accelerated forgetting in mice. Pharmacological inhibition of the ISR pathway using ISRIB preserves recognition memory and corrects accelerated forgetting, revealing new mechanistic and therapeutic insights for cognitive decline in epilepsy.